fb-pixel Skip to main content
Mass. coronavirus at a glance |
Vaccinations
Daily doses:
Weekly doses:
1+ dose received:
Fully vaccinated:
% of doses used:
7-day trend/avg.:
Cases and deaths
Cases
.
Deaths
.

More recent vaccine stories


Pfizer invests $470 million to develop tech behind COVID shot

The drugmaker will construct a new building and renovate existing facilities on its campus in Pearl River, New York to expand its vaccine research space.

Here is a list of lawmakers and others who were with Biden during his Mass. visit

President Biden tested positive for the coronavirus on Thursday, one day after his high-profile visit to the former Brayton Point power plant in Somerset, Mass., where he was in contact with a number of Massachusetts politicians and other guests.

Can you still use an at-home COVID-19 test past its expiration date? It depends.

The FDA has recently extended the shelf-lives of several popular test kit brands.

CDC advisers endorse more traditional Novavax COVID shot

Regulators authorized the nation’s first so-called protein vaccine against COVID-19 last week, but Novavax shots cannot begin until the Centers for Disease Control and Prevention recommends how to use them.

Massachusetts now offering monkeypox vaccines at 11 clinics across the state

The Massachusetts Department of Public Health announced Monday that 11 sites around the state are offering monkeypox vaccines to combat the spread of the virus in the area. Initially, just four locations were offering the vaccine.

Nearly 800,000 doses of monkeypox vaccine may be in US by end of July

The shots have been stored in Denmark awaiting the completion of the FDA on-the-ground inspection and authorization.

FDA authorizes Novavax COVID vaccine, adding a fourth shot to pandemic arsenal

Regulators Wednesday authorized the nation's fourth coronavirus vaccine, a shot developed by Novavax, a Maryland biotechnology company that has been a straggler in the vaccine race.

Here are 8 takeaways from the White House COVID news conference on the BA.5 subvariant

The White House COVID-19 response team held a news conference Tuesday in which officials focused on the threat posed by the rise of the highly transmissible BA.5 subvariant, what people can do to protect themselves, and what steps the government is taking.